Medprime Technologies, which deals with leading companies in the medical devices and diagnostics domain, has concluded its Pre-Series A fund round through the investments of Ashish Kacholia, co-founder Hungama Digital and Significant investor in India. The growth is going to be very high, and Medprime will be able to capture the international market of its flagship product, CILIKA.
Medprime’s attempt to revolutionize the medical diagnostics of India will see investment made in the advanced modules of Artificial Intelligence in MICALYS. Moreover, the funds would be used for the upgrading of the manufacturing capacity of the company, leading to increased productivity due to enhanced efficiency and to meet the growing demand of the products worldwide.
Medprime is indeed leading the way in digital microscopy. The devices have been used by several medical colleges and research institutions in India, including the country’s premier medical college, AIIMS, and Maulana Azad Medical College. This has been possible because its healthcare solutions are effective in every way.
MICALYS is one of the leaders in AI-driven healthcare innovations, and the newly developed AI module would definitely make Medprime’s aim of enhancing the diagnostic processes stronger. Ashish Kacholia said, “The future of health care is in the intersection of technology and medicine. I feel this alliance will bring significant developments in diagnostics.”
Apart from AI-driven enhancements, Medprime has aims to streamline its manufacturing processes for the convenience of healthcare professionals across the globe. Co-founder Greeshma Unnikrishnan welcomed Kacholia aboard and said, “We are thrilled to have Mr. Kacholia on board. His investment and vision will add to our mission of transforming healthcare through innovation.”
Medprime, founded in 2014 by alumni from IIT Bombay, is backed by some of the significant global players like USAID-backed SAMRIDH besides leading academic institutions and venture capital firms. This fund raising places Medprime strongly for sustained growth with innovations in the healthtech sector.
Read More: Click Here
